Kateera (Cochlospermum religiosum)

Kateera (Cochlospermum religiosum) is a traditional Unani medicine containing myricetin as its primary bioactive compound. It exhibits antimicrobial and anti-inflammatory properties through myricetin's inhibition of inflammatory mediators and oxidative pathways.

Origin & History

Kateera, also known as Katira gum, is a natural exudate obtained from the stem bark of Cochlospermum religiosum trees native to tropical regions of India and Africa. The gum forms in response to physical injury, stress, or fungal attack and consists primarily of D-galactose, D-galacturonic acid, and L-rhamnose polysaccharides.

Historical & Cultural Context

In Indian traditional medicine, Cochlospermum religiosum has been used for centuries, with the tree considered sacred and often planted near temples. The gum has been traditionally used in formulations for treating gonorrhea and as an adjuvant in various herbal preparations, with historical phytochemical research dating back to 1950-1970.

Health Benefits

• Traditional antimicrobial properties - Used in formulations for gonorrhea treatment (evidence quality: traditional use only)
• Anti-inflammatory potential - Contains myricetin with preliminary anti-inflammatory properties (evidence quality: in-vitro studies only)
• Antioxidant activity - Myricetin component shows antioxidant properties in preliminary research (evidence quality: in-vitro studies only)
• Gastrointestinal support - Used as pharmaceutical agent for colon-targeted drug delivery (evidence quality: pharmaceutical application only)
• Anti-carcinogenic potential - Contains myricetin with preliminary antineoplastic properties (evidence quality: in-vitro studies only)

How It Works

Myricetin, the primary bioactive compound in Kateera, inhibits nuclear factor-kappa B (NF-κB) signaling pathways, reducing pro-inflammatory cytokine production. It also scavenges reactive oxygen species through direct antioxidant activity and modulates inflammatory enzyme expression. The antimicrobial effects likely involve disruption of bacterial cell membrane integrity.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Kateera gum. Research is limited to phytochemical analysis and pharmaceutical applications, with structural analysis detailed in PMID 18374321 focusing on polysaccharide composition rather than clinical outcomes.

Clinical Summary

Evidence for Kateera is limited to traditional use documentation and preliminary in-vitro studies. Laboratory studies have demonstrated myricetin's anti-inflammatory activity in cell culture models, but no human clinical trials exist. Traditional Unani texts document its use in treating gonorrhea and inflammatory conditions, but these lack controlled study validation. Current evidence quality remains insufficient for establishing clinical efficacy.

Nutritional Profile

{"macronutrients": {"protein": "2.5 g per 100 g", "fiber": "3.0 g per 100 g"}, "micronutrients": {"vitamin_C": "15 mg per 100 g", "calcium": "40 mg per 100 g", "iron": "1.5 mg per 100 g"}, "bioactive_compounds": {"myricetin": "5 mg per 100 g"}, "bioavailability_notes": "The bioavailability of myricetin may be enhanced when consumed with fats. Vitamin C is water-soluble and readily absorbed, while the absorption of iron may be improved when consumed with vitamin C-rich foods."}

Preparation & Dosage

No clinically studied dosage ranges are available due to absence of human trials. Pharmaceutical applications use Katira gum as a suspending agent or matrix coating at low concentrations without standardized therapeutic dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other Unani herbs, Turmeric, Ginger, Neem, Triphala

Safety & Interactions

Safety data for Kateera is extremely limited due to lack of clinical studies. Traditional use suggests general tolerability, but specific adverse effects, drug interactions, and contraindications remain undocumented. Pregnancy and breastfeeding safety is unknown and should be avoided. Potential interactions with anticoagulant medications may exist due to myricetin content, requiring medical supervision.